Comparative Assessment of Effectiveness and Safety of Lumbar Erector Spinae Plane Block Versus No Locoregional Block in Hip Surgery

What this Trial Is About

Hip surgery is common, especially among elderly patients with multiple health conditions, where managing pain effectively can be challenging due to concerns about side effects and drug interactions. Researchers are evaluating whether the lumbar erector spinae plane block (L-ESP block), an ultrasound-guided regional anesthesia technique, can reduce opioid use and improve pain relief after hip and proximal femur surgeries. Participants will be randomly assigned to receive either the L-ESP block with 30 mL of levobupivacaine 0.25% at the L3-14 level after hip fracture surgery or conventional intravenous pain treatment without the block. The study compares pain reduction and opioid needs following surgery between these two groups. During the study, participants’ pain levels will be measured using the VAS scale within the first two hours after surgery. Researchers will also monitor opioid consumption, technical ease of performing the block, patient satisfaction with pain management, and side effects related to the block and morphine up to 48 hours postoperatively. The trial begins in June 2024 and continues through December 2025.

Comparative Assessment of Effectiveness and Safety of L-ESPB Versus Absence of Locoregional Block in Hip Surgery